ANDERA PARTNERS
CIK
1757283
Location
PARIS, I0
Portfolio Value
Small
$176,916,070
Diversification
Moderately concentrated
Filing Date
Global Rank
#4,143
/ 8,232
▲ 239
Top Industry
Biotechnology
68.8%
3Y Alpha vs SPY
-86.2%
Period ended 2 months ago
Filed May 11, 2026 · 34d
2 quarters · since Dec 2025
Clone Performance
Feb 2026–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-23.6%
SPY
+9.1%
Annualised alpha
-86.2%
Max drawdown
−25.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
7 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
30.4%
−7.8 pts
Top 5
94.2%
−5.8 pts
Top 10
100.0%
0.0 pts
HHI
2,265
Moderately concentrated−657
Portfolio Trend
2 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $176,916,070 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| KMTS | Kestra Medical Technologies, Ltd. | +155,086 | 2,695,192 | $53,715,176 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
7 positions ·
$176,916,070 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| KMTS |
Kestra Medical Technologies, Ltd.
Healthcare
|
Added | 2,695,192 | $53,715,176 | 30.36% | |
| EVMN |
Evommune, Inc.
Healthcare
|
Held | 1,897,362 | $43,620,352 | 24.66% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Held | 1,591,917 | $43,125,031 | 24.38% | |
| AGMB |
Agomab Therapeutics NV
Healthcare
|
NEW | 1,538,702 | $16,140,983 | 9.12% | |
| IVA |
Inventiva S.A.
Healthcare
|
Reduced | 1,818,181 | $10,090,904 | 5.70% | |
| ABVX |
Abivax S.A.
Healthcare
|
Held | 78,125 | $8,699,218 | 4.92% | |
| NYXH |
Nyxoah SA
Healthcare
|
NEW | 522,057 | $1,524,406 | 0.86% |